Please contact ProSciento’s corporate communications director at abby.devine@prosciento.com for any earlier archived news releases.
September 17, 2021
ProSciento Appoints Michelle Thompson, PhD, MBA, as Executive Vice President of Global Business Development Read More »
July 8, 2021
ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science Read More »
September 10, 2020
ProSciento Closes Growth Financing from 1315 Capital Read More »
September 1, 2020
ProSciento Appoints Stephen Mullennix as Chief Financial Officer Read More »
June 15, 2020
ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California Read More »
February 11, 2020
ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »
February 6, 2020
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH) Read More »
November 12, 2019
ProSciento to Present at the Diabetes Technology Annual Meeting Read More »
August 13, 2019
ProSciento Expands Senior Management Team, Appoints Siva Mullapudi as Senior Director of CRO Services Read More »
August 5, 2019
ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting Read More »
June 17, 2019
ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer Read More »
May 29, 2019
ProSciento to Present at the American Diabetes Association 79th Scientific Sessions Read More »
April 15, 2019
ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit Read More »
April 10, 2019
Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research Read More »
March 19, 2019
ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna Read More »
January 2, 2019
ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference Read More »
December 5, 2018
ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs Read More »
October 26, 2018
ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting Read More »
September 27, 2018
ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting Read More »
August 6, 2018
ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer Read More »
June 21, 2018
ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials Read More »
June 20, 2018
ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team Read More »
June 13, 2018
ProSciento to Present at the American Diabetes Association 78th Scientific Sessions Read More »
April 19, 2018
ProSciento Presents Scientific Data at the 2nd Annual Nash Summit Read More »
March 7, 2018
ProSciento Expands Asia Pacific Operations with Office in Australia Read More »
November 6, 2017
ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit Read More »
September 9, 2017
ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon Read More »
June 7, 2017
ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment Read More »
June 6, 2017
ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego Read More »
May 30, 2017
ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors Read More »
May 1, 2017
ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop Read More »
February 15, 2017
mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population Read More »
September 14, 2016
ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research Read More »
July 28, 2016
ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH Read More »
June 10, 2016
ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism Read More »
June 9, 2016
ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions Read More »
June 6, 2016
ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans Read More »
April 5, 2016
ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »
November 24, 2015
ProSciento Appoints Meryl Wiernik as Senior Director of CRO Services Read More »
November 9, 2015
Congratulations to Hanmi Pharmaceutical Co., Ltd. Read More »
October 29, 2015
ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego Read More »
October 28, 2015
ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research Read More »
October 28, 2015
ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH Read More »
October 13, 2015
ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year Read More »
October 8, 2015
ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development Read More »
September 10, 2015
ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting Read More »
June 4, 2015
ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership Read More »
May 30, 2015
ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston Read More »
May 7, 2015
ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt Read More »
April 15, 2015
ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »
January 22, 2015